ANTIVIRAL DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Class
     • Market Snapshot, By Type
     • Market Snapshot, By Application
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Regulatory Scenario
   • Acquisitions and Partnerships Scenario
   • Funding and Investments
   • PEST Analysis
   • Porter’s Analysis

4. Global Antiviral Drugs Market, By Drug Class, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • DNA Polymerase Inhibitors
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Reverse Transcriptase Inhibitors
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Protease Inhibitors
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Neuraminidase Inhibitors
   • Others
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

5. Global Antiviral Drugs Market, By Type, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Branded
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Generics
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

6. Global Antiviral Drugs Market, By Application, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • HIV
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Hepatitis
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Herpes
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Influenza
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Others
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

7. Global Antiviral Drugs Market, By Distribution Channel, 2021 – 2033, (USD Bn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 – 2033
     • Segment Trends
   • Hospital Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Retail Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
   • Online Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

8. Global Antiviral Drugs Market, By Region, 2021 – 2033, (USD Bn)

   • Introduction
     • Market Share Analysis, By Region, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Region, 2021–2033
     • Regional Trends

   • North America

     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
       • North Africa
       • Central Africa
       • South Africa

9. Competitive Landscape

   • Company Profiles
     • AbbVie Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • GSK plc
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Dr. Reddy's Laboratories Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • F. Hoffmann-La Roche Ltd
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Bristol-Myers Squibb Company
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Cipla
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Aurobindo Pharma
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Gilead Sciences, Inc. 
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Merck & Co., Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Zydus Group
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Atea Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Johnson & Johnson Services, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Sun Pharmaceutical Industries Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Pfizer Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Torrent Pharmaceuticals Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Arbutus Biopharma
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Divi's Laboratories Limited
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • RedHill Biopharma Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • ViiV Healthcare Pty Ltd.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies

10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

11. References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact